Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012
Number of items: 12.

2020

Held, Gerhard, Thurner, Lorenz, Poeschel, Viola, Berdel, Christian, Ott, German, Schmidt, Christian, Viardot, Andreas, Borchmann, Peter, Shpilberg, Ofer, Nickelsen, Maike, Federico, Massimo, Brown, Peter de Nully, Murawski, Niels, Trumper, Lorenz H., Schmidberger, Heinz, Ruebe, Christian, Fleckenstein, Jochen, Schmitz, Norbert, Loeffler, Markus, Ziepert, Marita and Alliance, German Lymphoma (2020). Role of radiotherapy and dose-densification of R-CHOP in primary mediastinal B-cell lymphoma: A subgroup analysis of the unfolder trial of the German Lymphoma Alliance (GLA). J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

2019

Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Kuhnert, Georg, Lohri, Andreas, Greil, Richard, Sasse, Stephanie, Topp, Max S., Schaefer, Erhardt, Hertenstein, Bernd, Soekler, Martin, Vogelhuber, Martin, Zijlstra, Josee M., Keller, Ulrich Bernd, Krause, Stefan W., Wilhelm, Martin, Maschmeyer, Georg, Thiemer, Julia, Duehrsen, Ulrich, Meissner, Julia, Viardot, Andreas, Eich, Hans, Baues, Christian, Diehl, Volker, Rosenwald, Andreas, von Tresckow, Bastian, Dietlein, Markus, Borchmann, Peter and Engert, Andreas (2019). Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group. J. Clin. Oncol., 37 (31). S. 2835 - 2847. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Poeschel, Viola, Held, Gerhard, Ziepert, Marita, Witzens-Harig, Mathias, Holte, Harald, Thurner, Lorenz, Borchmann, Peter, Viardot, Andreas, Soekler, Martin, Keller, Ulrich, Schmidt, Christian, Truemper, Lorenz, Mahlberg, Rolf, Marks, Reinhard, Hoeffkes, Heinz-Gert, Metzner, Bernd, Dierlamm, Judith, Frickhofen, Norbert, Haenel, Mathias, Neubauer, Andreas, Kneba, Michael, Merli, Francesco, Tucci, Alessandra ORCID: 0000-0003-3052-7463, Brown, Peter de Nully ORCID: 0000-0002-6522-4086, Federico, Massimo, Lengfelder, Eva, di Rocco, Alice, Trappe, Ralf ORCID: 0000-0001-7565-7160, Rosenwald, Andreas, Berdel, Christian, Maisenhoelder, Martin, Shpilberg, Ofer, Amam, Josif, Christofyllakis, Konstantinos ORCID: 0000-0002-0308-388X, Hartmann, Frank, Murawski, Niels, Stilgenbauer, Stephan, Nickelsen, Maike, Wulf, Gerald, Glass, Bertram, Schmitz, Norbert, Altmann, Bettina, Loeffler, Markus and Pfreundschuh, Michael (2019). Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial. Lancet, 394 (10216). S. 2271 - 2282. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-547X

2018

Poeschel, Viola, Held, Gerhard, Ziepert, Marita, Altmann, Bettina, Witzens-Harig, Mathias, Holte, Harald, Thurner, Lorenz, Viardot, Andreas, Borchmann, Peter, Kanz, Lothar, Keller, Ulrich, Schmidt, Christian, Mahlberg, Rolf, Metzner, Bernd, Marks, Reinhard, Hoeffkes, Heinz-Gert, Christofyllakis, Konstantinos, Amam, Josif, Berdel, Christian, Stilgenbauer, Stephan, Schmitz, Norbert, Truemper, Lorenz, Murawski, Niels, Loeffler, Markus and Pfreundschuh, Michael (2018). Excellent Outcome of Young Patients (18-60 years) with Favourable-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 4 Cycles CHOP Plus 6 Applications of Rituximab: Results of the 592 Patients of the Flyer Trial of the Dshnhl/GLA. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

von Tresckow, Bastian, Huettmann, Andreas, Vucinic, Vladan, Mueller, Horst, Pluetschow, Annette, Viardot, Andreas, Topp, Max S., Kobe, Carsten, Boell, Boris, Eichenauer, Dennis A., Sasse, Stephanie, Haverkamp, Heinz, Fuchs, Michael, Engert, Andreas and Borchmann, Peter (2018). Induction Therapy with Everolimus in Combination with DHAP (Dexamethasone, High-Dose AraC, Cisplatinum) in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma: A Randomized, Placebo-Controlled Phase I/II Trial (HD-R3i). Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

2017

Murawski, Niels, Miriam, Josif, Altmann, Bettina, Ziepert, Marita, Haenel, Mathias, Viardot, Andreas, Neubauer, Andreas, Held, Gerhard, Truemper, Lorenz, Schmidt, Christian, Kanz, Lothar, Hallek, Michael, Schmitz, Norbert, Heintges, Tobias, Koelbel, Christian, Poeschel, Viola and Pfreundschuh, Michael (2017). Anti-infective prophylaxis with aciclovir and cotrimoxazole to reduce the rate of infections and therapy-associated deaths in elderly patients with DLBCL undergoing R-CHOP immunochemotherapy. J. Clin. Oncol., 35. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Pfreundschuh, Michael, Christofyllakis, Konstantinos, Altmann, Bettina, Ziepert, Marita, Haenel, Mathias, Viardot, Andreas, Neubauer, Andreas, Held, Gerhard, Truemper, Lorenz, Schmidt, Christian, Kanz, Lothar, Hallek, Michael J., Schmitz, Norbert, Heintges, Tobias, Koelbel, Christian, Schneider, Guenther, Ruebe, Christian, Hellwig, Dirk ORCID: 0000-0002-3056-0143, Poeschel, Viola and Murawski, Niels (2017). Radiotherapy to bulky disease PET-negative after immunochemotherapy in elderly DLBCL patients: Results of a planned interim analysis of the first 187 patients with bulky disease treated in the OPTIMAL > 60 study of the DSHNHL. J. Clin. Oncol., 35. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

2015

Schmitz, Norbert, Nickelsen, Maike, Ziepert, Marita, Haenel, Mathias, Viardot, Andreas, Dreyling, Martin H., Borchmann, Peter, Bokemeyer, Carsten, Peschel, Christian, Wolf, Hans-Heinrich, Mahlberg, Rolf, Pfreundschuh, Michael and Glass, Bertram (2015). Optimization of Rituximab for Treatment of DLBCL in Young, High-Risk Patients-Results of the Dense-R-CHOEP Trial of the German High-Grade Lymphoma Study Group. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

2014

Pfreundschuh, Michael, Poeschel, Viola, Zeynalova, Samira, Haenel, Mathias, Held, Gerhard, Schmitz, Norbert, Viardot, Andreas, Dreyling, Martin H., Hallek, Michael, Mueller, Carsten, Wiesen, Martin H. J., Witzens-Harig, Mathias ORCID: 0000-0002-2799-4661, Truemper, Lorenz, Keller, Ulrich, Rixecker, Tanja, Zwick, Carsten and Murawski, Niels (2014). Optimization of Rituximab for the Treatment of Diffuse Large B-Cell Lymphoma (II): Extended Rituximab Exposure Time in the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group. J. Clin. Oncol., 32 (36). S. 4127 - 4135. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

2013

Held, Gerhard, Zeynalova, Samira, Murawski, Niels, Ziepert, Marita, Kempf, Barbara, Viardot, Andreas, Dreyling, Martin, Hallek, Michael, Witzens-Harig, Mathias ORCID: 0000-0002-2799-4661, Fleckenstein, Jochen, Ruebe, Christian, Zwick, Carsten, Glass, Bertram, Schmitz, Norbert and Pfreundschuh, Michael (2013). Impact of Rituximab and Radiotherapy on Outcome of Patients With Aggressive B-Cell Lymphoma and Skeletal Involvement. J. Clin. Oncol., 31 (32). S. 4115 - 4126. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

2012

Herfarth, Klaus, Engelhard, Marianne, Borchmann, Peter, Hohloch, Karin, Budach, Volker, Viardot, Andreas, Witzens-Harig, Mathias, Eich, Hans, Hiddemann, Wolfgang and Dreyling, Martin (2012). Treatment of Early Stage Nodal Follicular Lymphoma Using Involved-Field Radiotherapy and Rituximab: Preliminary Results of the Mir Trial (phase II study of the German Low Grade Lymphoma Study Group (GLSG)). Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Schmitz, Norbert, Nickelsen, Maike, Ziepert, Marita, Haenel, Mathias, Borchmann, Peter, Schmidt, Christian, Viardot, Andreas, Bentz, Martin, Peter, Norma, Ehninger, Gerhard, Doelken, Gottfried, Ruebe, Christian, Truemper, Lorenz, Rosenwald, Andreas, Pfreundschuh, Michael, Loeffler, Markus and Glass, Bertram (2012). Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1). Lancet Oncol., 13 (12). S. 1250 - 1260. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1470-2045

This list was generated on Sat Dec 4 01:34:44 2021 CET.